Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $5.8 million.

  • iSpecimen's Shares Outstanding (Diluted Average) rose 749.83% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 749.83%. This contributed to the annual value of $710,852 for FY2024, which is 57.24% up from last year.
  • iSpecimen's Shares Outstanding (Diluted Average) amounted to $5.8 million in Q3 2025, which was up 133.88% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Shares Outstanding (Diluted Average) ranged from a high of $9.0 million in Q2 2023 and a low of $452,067 during Q4 2023.
  • In the last 3 years, iSpecimen's Shares Outstanding (Diluted Average) had a median value of $710,852 in 2024 and averaged $2.9 million.
  • In the last 5 years, iSpecimen's Shares Outstanding (Diluted Average) spiked by 836.27% in 2022 and then crashed by 94.92% in 2024.
  • Quarterly analysis of 5 years shows iSpecimen's Shares Outstanding (Diluted Average) stood at $4.3 million in 2021, then surged by 106.28% to $8.8 million in 2022, then slumped by 94.89% to $452,067 in 2023, then surged by 57.24% to $710,852 in 2024, then soared by 749.83% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $2.5 million for Q2 2025, and $2.3 million during Q1 2025.